MEDIFAST (MED)
(Delayed Data from NYSE)
$12.85 USD
+0.11 (0.86%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $12.85 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MED 12.85 +0.11(0.86%)
Will MED be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MED
Hims & Hers Redefines Virtual Care With Integrated Tech Platforms
Medifast's Q2 Earnings Beat Estimates, Lower Revenues Hurt Margins
MED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clorox Q4 Earnings Beat Estimates, Organic Sales Increase Y/Y
Kraft Heinz Q2 Earnings Beat Estimates, Organic Sales Down 2% Y/Y
Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness
Other News for MED
Medifast Inc (MED) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
Q2 2025 Medifast Inc Earnings Call Transcript
Medifast signals limited use of promotions and unveils Premier+ pricing to drive coach retention
Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript
Here are the major earnings after the close Monday